ARCHIVES

Reduced Risk of Metastasis When Screening Finds Cancer

This article is from The Cancer Letter archive.

Vol. 27 No. 8 | August 27, 2004

Download PDF Visit The Full Archive

Related Articles

NSABP Submits Appeal To NIH To Reverse Cancellation Of P-4 Chemoprevention Trial.

August 10, 2007

Funding Opportunities.

April 19, 2002

Vectibix Non-Inferior to Erbitux In Wild-Type Metastatic Disease

October 25, 2013

Bad News for EPO Products Brings FDA Scrutiny, Payment Curbs. FDA Issues Alert to Doctors.

February 23, 2007

ASCO Recommends Against Routine Adjuvant Chemo For Stage II Colon Cancer

August 27, 2004

FDA Advisors Recommend Approval Of Topotecan for Ovarian Cancer

April 26, 1996